Novavax's COVID vaccine unanimously recommended by CDC advisers
CBSN
A panel of the Centers for Disease Control and Prevention's outside vaccine advisers voted unanimously on Tuesday to recommend use of Novavax's COVID-19 vaccine, clearing one of the final hurdles for a new fourth option for millions of unvaccinated adults.
Theoretically, the first shots can begin once CDC Director Dr. Rochelle Walensky formally signs off on the committee's vote, though it is unclear how many doses will actually be available for those eager to finally get immunized with Novavax's two-dose vaccine.
The Biden administration announced last week that it would make 3.2 million doses available for states to order. Spokespeople for the Department of Health and Human Services and Novavax did not respond to requests for comment on how soon all those doses will be distributed.
